We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

41 hedge funds and large institutions have $158M invested in NeuroDerm Ltd. Ordinary Shares in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 2

362% more capital invested

Capital invested by funds: $34.1M → $158M (+$124M)

286% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 7

129% more call options, than puts

Call options by funds: $2.03M | Put options by funds: $888K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

95% more funds holding

Funds holding: 21 → 41 (+20)

Holders
41
Holders Change
+20
Holders Change %
+95.24%
% of All Funds
1.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
27
Increased
11
Reduced
2
Closed
7
Calls
$2.03M
Puts
$888K
Net Calls
+$1.14M
Net Calls Change
+$1.14M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$30M
2
SCM
Scopia Capital Management
New York
+$27.6M
3
ACA
Avoro Capital Advisors
New York
+$15M
4
GC
GMT Capital
Georgia
+$11.6M
5
RCM
RA Capital Management
Massachusetts
+$8.72M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$11.5M
2
PVI
Pura Vida Investments
New York
-$1.01M
3
OM
Opaleye Management
Massachusetts
-$399K
4
OC
Oppenheimer & Co
New York
-$287K
5
Goldman Sachs
Goldman Sachs
New York
-$277K
Name Holding Trade Value Shares
Change 		Change in
Stake
RG
1
Redmile Group
California
$30.2M +$30M +1,462,699 New
SCM
2
Scopia Capital Management
New York
$27.8M +$27.6M +1,343,541 New
ACA
3
Avoro Capital Advisors
New York
$22.8M +$15M +731,982 +197%
GC
4
GMT Capital
Georgia
$13.1M +$11.6M +566,649 New
ACP
5
Acuta Capital Partners
California
$10.3M +$4.03M +196,630 +66%
RCM
6
RA Capital Management
Massachusetts
$8.79M +$8.72M +425,000 New
CCM
7
Cadian Capital Management
New York
$8.67M +$8.6M +419,315 New
BBA
8
Baker Bros. Advisors
New York
$6.3M +$1.13M +55,000 +22%
PA
9
Perceptive Advisors
New York
$5.58M +$1.44M +70,000 +35%
ACH
10
ArrowMark Colorado Holdings
Colorado
$2.57M +$2.55M +124,290 New
MMH
11
Menora Mivtachim Holdings
Israel
$2.27M +$64.1K +3,126 +3%
GTC
12
Ghost Tree Capital
New York
$2.07M +$2.05M +100,000 New
Millennium Management
13
Millennium Management
New York
$1.99M +$1.97M +96,192 New
BIM
14
Bogle Investment Management
Massachusetts
$1.94M +$1.93M +93,869 New
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$1.9M +$1.88M +91,739 New
SFM
16
Sphera Funds Management
Israel
$1.76M +$1.74M +85,000 New
FCMI
17
Foresite Capital Management II
California
$1.59M +$49.6K +2,416 +3%
AIC
18
AWM Investment Company
New York
$1.55M +$1.54M +75,000 New
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$1.19M +$1.19M +57,786 New
SAM
20
Senzar Asset Management
New York
$1.16M +$1.15M +56,000 New
EI
21
EAM Investors
California
$758K +$752K +36,686 New
Morgan Stanley
22
Morgan Stanley
New York
$694K +$522K +25,467 +315%
GL
23
GLG LLC
New York
$521K +$517K +25,198 New
QSS
24
Quantitative Systematic Strategies
Florida
$425K +$422K +20,564 New
MC
25
Menta Capital
California
$378K +$376K +18,310 New
1
2

NDRM Hedge Fund Activity: Q3 2015 in Review

41 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q3 2015, worth a combined $158M — up 362% from $34.1M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new NDRM positions and 7 closed out — a net gain of 20 holders — while 11 added to existing stakes and 2 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $30M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $11.5M sold.

  • 41 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q3 2015, up from 21 in Q2 2015.
  • Funds reported $158M of NeuroDerm Ltd. Ordinary Shares stock for Q3 2015, up 362% quarter-over-quarter.
  • 27 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q3 2015 and 7 closed out, a net change of +20 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q3 2015 was Redmile Group, an estimated $30M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q3 2015 was Adage Capital Partners, an estimated $11.5M sold.

Based on aggregated 13F filings for Q3 2015.